Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Jun 20;23(1):1188.
doi: 10.1186/s12889-023-16104-w.

The effectiveness of a health education intervention to reduce anxiety in quarantined COVID-19 patients: a randomized controlled trial

Affiliations
Randomized Controlled Trial

The effectiveness of a health education intervention to reduce anxiety in quarantined COVID-19 patients: a randomized controlled trial

Imen Zemni et al. BMC Public Health. .

Abstract

Introduction: The COVID-19 pandemic is regarded as a serious public health concern that boosts levels of stress and anxiety which could be explained by several reasons, including social isolation. In this regard, we aimed to assess the impact of health education on the anxiety level of COVID-19 patients during the isolation period.

Methods: This is a randomized controlled trial conducted between February 2021 and June 2021. Patients tested positive for Covid-19 with mild to moderate forms were randomized to Education (n = 267) or control (n = 269). The education group received a phone health education session on day 1 (D1) following the diagnosis. The three components of the health education intervention were an explanation of the coronavirus disease, what to do in the event of complications, and the recommended preventive measures. The two groups received a telephone evaluation of their Hospital Anxiety and Depression scores on D1 and day seven D7 following the positive diagnosis. The primary outcome was the rate of anxiety reduction in each group on D7 based on a HAD-A score ≥ 8. Secondary outcomes were the rate of anxiety reduction on D7 based on a HAD-A score ≥ 11, the percentage of people complying with isolation and the scores of adherences to preventive measures during the isolation in each group.

Results: Hundred and ninety-six patients in the intervention group and 206 patients in the control group completed the study. The sociodemographic, clinical, and initial anxiety level features of the intervention and control groups were comparable at baseline (p ≥ 0.05). On D7, the education group's anxiety level (HAD-A ≥ 8) decreased from 26 to 16.3% (p = 0.013) while in the control group it increased from 19.4 to 22.8% (p = 0.37). Thus, the percentage change in anxiety between D1 and D7 (delta D7 - D1) was - 9.7% in the Education group and + 3.4% in the Control group. Using the HAD-A ≥ 11 thresholds, the percentage of anxiety decreased from 15.3 to 11.2% (p = 0.26) between D1 and D7, while it increased in the control group from 9.7 to 15.7% (p = 0.045). Thus, the education group's change in anxiety (delta D7 - D1) was - 4.1%, while the control group's change was + 6%.

Conclusion: During an outbreak, providing health education to quarantined patients may be beneficial to reduce the psychological impact of the disease.

Trial registration number: ClinicalTrials.gov Identifier: NCT05715593, retrospectively registered on 8/02/2023 https://clinicaltrials.gov/ct2/results?term=NCT05715593&Search=Search .

Keywords: Anxiety; COVID-19; Health education; Pandemic; Quarantine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow Diagram
Fig. 2
Fig. 2
Comparison between baseline and final anxiety prevalence according to the Anxiety subscale of the HAD Scale among the two study groups
Fig. 3
Fig. 3
Variation of anxiety prevalence between day1 and day7 among the two study groups
Fig. 4
Fig. 4
Comparison between distribution of baseline and final HADS-A scores among the two study groups
Fig. 5
Fig. 5
HADS-A scores difference (day7-day1) among the two groups

Similar articles

Cited by

References

    1. WHO Coronavirus (COVID-19) Dashboard, https://covid19.who.int (accessed 31. May 2023).
    1. Tunisia. WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data, https://covid19.who.int (accessed 31 May 2023).
    1. #HealthyAtHome. https://www.who.int/campaigns/connecting-the-world-to-combat-coronavirus... (accessed 31 May 2023).
    1. Dong L, Bouey J. Public Mental Health Crisis during COVID-19 pandemic, China. Emerg Infect Dis. 2020;26:1616–8. doi: 10.3201/eid2607.200407. - DOI - PMC - PubMed
    1. Brahimi G, Larinouna A, Ait S et al. Etude épidémiologique des patients atteints de Covid- 19 reçus au CHU Béni- Messous du 11 Mars-30 Avril 2020: Résultats préliminaires. 7.

Publication types

Associated data